Non-Small Cell Lung Cancer (NSCLC, Locally Advanced or Metastatic, Second-line
2 clinical trials · Condition
◉ Watch Non-Small Cell Lung Cancer (NSCLC, Locally Advanced or Metastatic, Second-line
| Record | Firm | Date |
|---|---|---|
| The Study Of Andamertinib Plus Anlotinib In Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NCT07780578) | Fudan University | 2026-09-30 |
| This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Non-small Cell Lung Cancer. (NCT00047840) | Genzyme, a Sanofi Company | 2002-10-01 |
Track Non-Small Cell Lung Cancer (NSCLC, Locally Advanced or Metastatic, Second-line automatically
Every clearance here is in the API, with alerts when new ones post.